A detailed history of Cabot Wealth Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cabot Wealth Management Inc holds 2,024 shares of MRK stock, worth $202,116. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,024
Previous 1,979 2.27%
Holding current value
$202,116
Previous $245,000 6.53%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $5,001 - $5,803
45 Added 2.27%
2,024 $229,000
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $10,770 - $11,567
-87 Reduced 4.21%
1,979 $245,000
Q1 2024

May 02, 2024

BUY
$113.24 - $131.95 $1,585 - $1,847
14 Added 0.68%
2,066 $272,000
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $5,710 - $6,214
57 Added 2.86%
2,052 $223,000
Q3 2023

Oct 26, 2023

BUY
$102.95 - $114.33 $3,603 - $4,001
35 Added 1.79%
1,995 $205,000
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $171,382 - $219,735
1,960 New
1,960 $217,000
Q1 2021

Apr 20, 2021

SELL
$68.86 - $81.11 $211,951 - $249,656
-3,078 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $6,674 - $7,407
93 Added 3.12%
3,078 $252,000
Q3 2020

Nov 05, 2020

BUY
$73.18 - $82.95 $5,268 - $5,972
72 Added 2.47%
2,985 $248,000
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $205,133 - $233,418
2,913 New
2,913 $225,000
Q1 2020

Apr 23, 2020

SELL
$63.36 - $87.82 $160,680 - $222,711
-2,536 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $46,201 - $52,695
-664 Reduced 20.75%
2,536 $211,000
Q3 2018

Oct 30, 2018

BUY
$57.69 - $67.84 $184,608 - $217,088
3,200 New
3,200 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cabot Wealth Management Inc Portfolio

Follow Cabot Wealth Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cabot Wealth Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cabot Wealth Management Inc with notifications on news.